» Articles » PMID: 23235713

Association of Seasonal Variation in the Prevalence of Metabolic Syndrome with Insulin Resistance

Overview
Journal Hypertens Res
Date 2012 Dec 14
PMID 23235713
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to examine the hypothesis that seasonal variation in the prevalence of metabolic syndrome (MetS) is associated with increased insulin resistance. Among 840 Japanese male workers who were evaluated using the homeostasis model assessment of insulin resistance (HOMA-IR) in June (summer) 2010, we prospectively studied a total of 758 subjects (40-65 years of age) who underwent an assessment in December (winter) 2010. MetS was defined according to the criteria proposed by the International Diabetes Federation (IDF) and the Japanese Society of Internal Medicine (JSIM). The median level of HOMA-IR in the study subjects was 0.84 (interquartile range: 0.60-1.19). The prevalence rates of IDF- and JSIM-MetS significantly increased from 12.4 and 9.6% in the summer to 16.6 and 13.3% in the winter, respectively (each P<0.05). Our data suggest that these increases are mainly due to increases in blood pressure (BP) and glucose during the winter assessment. The prevalence rates of IDF-MetS in the first, second, third and fourth quartiles of HOMA-IR were 1.1, 5.8, 14.3 and 29.1% in the summer and 3.1, 10.6, 21.9, and 31.3% in the winter, respectively. Similar results were obtained when using the JSIM criteria. In the third quartile, the frequency of elevated BP increased from 42.4% in the summer to 61.2% in the winter (P<0.05), and these values were mainly correlated with significant variations in IDF- and JSIM-MetS prevalence rates. This study demonstrates that seasonal variation in MetS prevalence is associated with mildly to moderately increased insulin resistance in middle-aged Japanese men.

Citing Articles

Seasonal variations of the prevalence of metabolic syndrome and its markers using big-data of health check-ups.

Seto H, Toki H, Kitora S, Oyama A, Yamamoto R Environ Health Prev Med. 2024; 29:2.

PMID: 38246652 PMC: 10808004. DOI: 10.1265/ehpm.23-00216.


Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.

Cincotta A Int J Mol Sci. 2023; 24(17).

PMID: 37686060 PMC: 10487918. DOI: 10.3390/ijms241713255.


Grape Seed Proanthocyanidins Modulate the Hepatic Molecular Clock via MicroRNAs.

Manocchio F, Soliz-Rueda J, Ribas-Latre A, Bravo F, Arola-Arnal A, Suarez M Mol Nutr Food Res. 2022; 66(23):e2200443.

PMID: 36189890 PMC: 10078170. DOI: 10.1002/mnfr.202200443.


Seasonal variation of vasopressin and its relevance for the winter peak of cardiometabolic disease: A pooled analysis of five cohorts.

Enhorning S, Melander O, Engstrom G, Elmstahl S, Lind L, Nilsson P J Intern Med. 2022; 292(2):365-376.

PMID: 35340071 PMC: 7613412. DOI: 10.1111/joim.13489.


Development and Validation of an Insulin Resistance Predicting Model Using a Machine-Learning Approach in a Population-Based Cohort in Korea.

Park S, Kim C, Wu X Diagnostics (Basel). 2022; 12(1).

PMID: 35054379 PMC: 8774355. DOI: 10.3390/diagnostics12010212.